Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sutton

Showing results (501-510 of 512) with videos related to

Pageof 52
Sort By:
Lancet (London, England)|July 29, 2017
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trialDavid A Margolis, Juan Gonzalez-Garcia, Hans-Jürgen Stellbrink, et al.
Nature Communications|January 22, 2025
Myosin-based nucleation of actin filaments contributes to stereocilia development critical for hearingZane G Moreland, Fangfang Jiang, Carlos Aguilar, et al.
Open Forum Infectious Diseases|September 24, 2021
Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 StudyGraham H R Smith, W Keith Henry, Daniel Podzamczer, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2008
Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1Haixia Wang, Zheming Ruan, James J Li, et al.
Journal of Medicinal Chemistry|April 9, 2009
N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientationAlexandra A Nirschl, Yan Zou, Stanley R Krystek, et al.
Research Square|December 4, 2023
Epistasis regulates genetic control of cardiac hypertrophyQianru Wang, Tiffany M Tang, Nathan Youlton, et al.
Nature Cardiovascular Research|June 5, 2025
Epistasis regulates genetic control of cardiac hypertrophyQianru Wang, Tiffany M Tang, Michelle Youlton, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Epistasis regulates genetic control of cardiac hypertrophyQianru Wang, Tiffany M Tang, Nathan Youlton, et al.
Journal of Medicinal Chemistry|June 10, 2021
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of CancerKevin D Freeman-Cook, Robert L Hoffman, Douglas C Behenna, et al.
Journal of Alzheimer'S Disease : JAD|October 16, 2023
Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression ProtocolAhmed A Bahrani, Erin L Abner, Charles S DeCarli, et al.
Pageof 52

Showing results (501-510 of 512) with videos related to

Sort By:
Pageof 52
Lancet (London, England)|July 29, 2017
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trialDavid A Margolis, Juan Gonzalez-Garcia, Hans-Jürgen Stellbrink, et al.
Nature Communications|January 22, 2025
Myosin-based nucleation of actin filaments contributes to stereocilia development critical for hearingZane G Moreland, Fangfang Jiang, Carlos Aguilar, et al.
Open Forum Infectious Diseases|September 24, 2021
Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 StudyGraham H R Smith, W Keith Henry, Daniel Podzamczer, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2008
Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1Haixia Wang, Zheming Ruan, James J Li, et al.
Journal of Medicinal Chemistry|April 9, 2009
N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientationAlexandra A Nirschl, Yan Zou, Stanley R Krystek, et al.
Research Square|December 4, 2023
Epistasis regulates genetic control of cardiac hypertrophyQianru Wang, Tiffany M Tang, Nathan Youlton, et al.
Nature Cardiovascular Research|June 5, 2025
Epistasis regulates genetic control of cardiac hypertrophyQianru Wang, Tiffany M Tang, Michelle Youlton, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Epistasis regulates genetic control of cardiac hypertrophyQianru Wang, Tiffany M Tang, Nathan Youlton, et al.
Journal of Medicinal Chemistry|June 10, 2021
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of CancerKevin D Freeman-Cook, Robert L Hoffman, Douglas C Behenna, et al.
Journal of Alzheimer'S Disease : JAD|October 16, 2023
Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression ProtocolAhmed A Bahrani, Erin L Abner, Charles S DeCarli, et al.
Pageof 52